🔎 Trials Near Me

Home › Kanser sa Dugo › Utah › Salt Lake City

Pag-aaral pangklinika para sa Kanser sa Dugo sa Salt Lake City, UT

Isang pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Salt Lake City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Nagre-recruitPhase 2
  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • University of Utah, Salt Lake City
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Nagre-recruitObservasyonal na pag-aaral
  • Primary Children's Hospital, Salt Lake City
Hanggang edad 30 · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06579469

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Nagre-recruitObservasyonal na pag-aaral
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT05663502

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Nagre-recruitPhase 1
  • University of Utah, Salt Lake City
Edad 13 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT04771572

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Nagre-recruitPhase 3
  • Primary Children's Hospital, Salt Lake City
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update May 5, 2026 · NCT05711667

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • Primary Children's Hospital, Salt Lake City
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Kanser sa Dugo sa ibang lungsod

Iba pang pag-aaral sa Salt Lake City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.